Search Results

Belizatinib 10 mg  | 99.48%

TargetMol

Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.

More Information Supplier Page

Belizatinib 5 mg  | 99.48%

TargetMol

Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.

More Information Supplier Page

Belizatinib 2 mg  | 99.48%

TargetMol

Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.

More Information Supplier Page

MQAE 100 mg  | 98.45%

TargetMol

MQAE, a fluorescent chloride ion indicator, is more sensitive and selective than 36Cl and microelectrode-based methods for chloride measurement in cells. MQAE is quenched via collision with chloride.

More Information Supplier Page

MQAE 50 mg  | 98.45%

TargetMol

MQAE, a fluorescent chloride ion indicator, is more sensitive and selective than 36Cl and microelectrode-based methods for chloride measurement in cells. MQAE is quenched via collision with chloride.

More Information Supplier Page

RO8994 25 mg  | 98.87%

TargetMol

RO8994 is a highly effective and specific inhibitor of spiroindolinone small-molecule MDM2, with IC50 of 20 nM (MTT proliferation assays) and 5 nM (HTRF binding assays).

More Information Supplier Page

RO8994 2 mg  | 98.87%

TargetMol

RO8994 is a highly effective and specific inhibitor of spiroindolinone small-molecule MDM2, with IC50 of 20 nM (MTT proliferation assays) and 5 nM (HTRF binding assays).

More Information Supplier Page

Olumacostat Glasaretil 100 mg  | 98.00%

TargetMol

Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). It has been used in trials studying the treatment of Acne Vulgaris.

More Information Supplier Page